Circulation, Vol 81, 586-592, Copyright © 1990 by American Heart Association
WB Moskowitz, M Mosteller, RM Schieken, R Bossano, JK Hewitt, JN Bodurtha and JP Segrest
We investigated the cardiovascular effects of lifelong passive cigarette
smoke exposure in preadolescent children and examined the following
questions: 1) Is systemic oxygen transport altered? 2) Are coronary heart
disease risk factors adversely affected? We recruited 216 families from the
MCV Twin Study; 105 had at least one smoking parent. Serum thiocyanate and
cotinine levels were used as measures of smoke exposure in the children and
thiocyanate was proportional to the number of parental cigarettes smoked
each day (p = 0.0001). Paternal smoking had no effect on these measures.
Whole blood 2,3- diphosphoglycerate was higher in smoke-exposed than
unexposed children (p less than 0.01) and was related to the thiocyanate
level (p less than 0.02). High density lipoprotein (HDL) cholesterol was
lower in passive smoking children (p less than 0.05); the HDL2 subfraction
was reduced in passive smoking boys, while the HDL3 subfraction was reduced
in passive smoking girls. Significant adverse alterations in systemic
oxygen transport and lipoprotein profiles are already present in
preadolescent children exposed to long-term passive cigarette smoke,
primarily from maternal smoke. Children with long-term exposure to passive
smoke may be at elevated risk for the development of premature coronary
heart disease.
ARTICLES
Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study
Children's Medical Center, Department of Human Genetics of the Medical College of Virginia, Richmond.
This article has been cited by other articles:
![]() |
D. Best, Committee on Environmental Health, Committee on Native American Child Health, and Committee on Adolescence Secondhand and Prenatal Tobacco Smoke Exposure Pediatrics, November 1, 2009; 124(5): e1017 - e1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Narkiewicz Second-hand smoke--a license to kill due to expire Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1508 - 1511. [Full Text] [PDF] |
||||
![]() |
J. Barnoya and S. A. Glantz Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking Circulation, May 24, 2005; 111(20): 2684 - 2698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. West, P. S. Romano, R. Azari, A. Rudominer, M. Holman, and S. Sandhu Impact of Environmental Tobacco Smoke on Children With Sickle Cell Disease Arch Pediatr Adolesc Med, December 1, 2003; 157(12): 1197 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Moskowitz, P. F. Schwartz, and R. M. Schieken Childhood Passive Smoking, Race, and Coronary Artery Disease Risk: The MCV Twin Study Arch Pediatr Adolesc Med, May 1, 1999; 153(5): 446 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Neufeld, M. Mietus-Snyder, A. S. Beiser, A. L. Baker, and J. W. Newburger Passive Cigarette Smoking and Reduced HDL Cholesterol Levels in Children With High-Risk Lipid Profiles Circulation, September 2, 1997; 96(5): 1403 - 1407. [Abstract] [Full Text] |
||||
![]() |
G. Scherer and E. Richter Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal Human and Experimental Toxicology, August 1, 1997; 16(8): 449 - 459. [Abstract] [PDF] |
||||
![]() |
K.A. Roberts, A.A. Rezai, K.E. Pinkerton, and J.C. Rutledge Effect of Environmental Tobacco Smoke on LDL Accumulation in the Artery Wall Circulation, November 1, 1996; 94(9): 2248 - 2253. [Abstract] [Full Text] |
||||
![]() |
D. S. Celermajer, M. R. Adams, P. Clarkson, J. Robinson, R. McCredie, A. Donald, and J. E. Deanfield Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults N. Engl. J. Med., January 18, 1996; 334(3): 150 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kritz, P. Schmid, and H. Sinzinger Passive Smoking and Cardiovascular Risk Arch Intern Med, October 9, 1995; 155(18): 1942 - 1948. [Abstract] [PDF] |
||||
![]() |
S. A. Glantz and W. W. Parmley Passive Smoking and Heart Disease: Mechanisms and Risk JAMA, April 5, 1995; 273(13): 1047 - 1053. [Abstract] [PDF] |
||||
![]() |
R. S. Rosenson Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management Arch Intern Med, July 12, 1993; 153(13): 1528 - 1538. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |